Alanine Aminotransferase (ALT) Test Methods: Principles, Procedures, and Applications

Alanine aminotransferase (ALT, also known as SGPT) testing is one of the most frequently performed laboratory assays for evaluating liver function and detecting hepatocellular injury. This technical article explains the enzyme's biochemical background, sample requirements, measured parameters, principal testing methods including the IFCC kinetic UV method and colorimetric procedures, and clinical applications. It serves as a practical reference for clinical laboratories, point-of-care testing programs, and researchers involved in liver health assessment.

Technical Overview

Alanine aminotransferase (ALT; EC 2.6.1.2), formerly known as serum glutamate pyruvate transaminase (SGPT) or glutamate pyruvate transaminase (GPT), is a pyridoxal phosphate-dependent cytosolic enzyme. It catalyzes the reversible transfer of an amino group from L-alanine to 2-oxoglutarate (α-ketoglutarate), producing pyruvate and L-glutamate.

ALT is present at its highest concentration in the cytosol of hepatocytes, with considerably lower activity in the kidney, heart, skeletal muscle, and pancreas. Because of this distribution, serum ALT is widely regarded as one of the most liver-specific laboratory biomarkers of hepatocellular injury. When hepatocyte membrane integrity is compromised by viral infection, toxic injury, ischemia, steatosis, or autoimmune damage, ALT is released into the sinusoidal blood and serum activity rises, often before changes in bilirubin or alkaline phosphatase become apparent.

Typical adult reference intervals at 37°C are approximately 7–33 U/L (0.12–0.55 µkat/L) for women and 7–45 U/L (0.12–0.75 µkat/L) for men, although laboratories must establish or verify method-specific ranges. Modern assays are standardized against the IFCC reference measurement procedure at 37°C, and results must state the measurement temperature because enzyme activity increases by roughly 7% per degree Celsius.

Testing Samples

Serum (Preferred Sample)

Venous blood is collected into a plain tube or a serum separator tube (SST), allowed to clot for 20–30 minutes at room temperature, and centrifuged at 1,500–2,000 × g for approximately 10 minutes. A typical required volume is 0.5–1.0 mL of serum, depending on the analyzer. Collection technique should minimize hemolysis: avoid prolonged tourniquet application, traumatic venipuncture, and vigorous tube mixing.

Plasma

Lithium heparin or EDTA plasma is acceptable for many commercial reagent systems, provided the reagent manufacturer's instructions confirm matrix compatibility. Citrate plasma introduces a dilution effect and may yield results approximately 10% lower than serum. Consistency of sample matrix is recommended when serial monitoring is performed.

Sample Handling and Stability

• Room temperature (20–25°C): stable for approximately 24 hours.
• Refrigerated (2–8°C): stable for up to 3 days.
• Frozen (-20°C or below): stable for at least 1 month; avoid repeated freeze–thaw cycles.
• Keep tubes tightly capped to prevent evaporation and concentration artifacts.

Interferences and Pre-Analytical Factors

• Hemolysis: erythrocytes contain ALT; leakage causes falsely elevated results, so grossly hemolyzed samples should be rejected.
• Lipemia: turbidity scatters light at 340 nm; clarification by high-speed centrifugation or use of a sample blank is recommended.
• Icterus: very high bilirubin concentrations can absorb in the measurement wavelength region.
• Endogenous pyruvate and ketone bodies: consumed during pre-incubation; markedly elevated levels can prolong the lag phase.
• Physiological factors: strenuous exercise, recent alcohol intake, obesity, and hepatotoxic medications (e.g., statins, NSAIDs, certain antibiotics, herbal supplements) can alter true ALT activity.

Testing Items

The primary measured item is the catalytic activity concentration of ALT in serum or plasma, reported in U/L (µmol substrate converted per minute per liter) or µkat/L.

• ALT activity as a single analyte for liver injury screening and monitoring.
• Comprehensive liver panel testing in combination with AST, ALP, GGT, total and direct bilirubin, total protein, and albumin.
• Derived calculations such as the AST/ALT ratio (De Ritis ratio), which supports etiological assessment of liver disease.
• Serial ALT measurements for evaluating disease kinetics and treatment response.

Testing Methods

IFCC Kinetic Ultraviolet (Continuous-Monitoring) Method

This is the internationally recommended method for routine ALT determination on automated clinical chemistry analyzers. ALT activity is measured through a coupled indicator reaction in which pyruvate formed by ALT is reduced to lactate by lactate dehydrogenase (LDH) with simultaneous oxidation of NADH to NAD+. The rate of NADH disappearance, monitored as a decrease in absorbance at 340 nm, is directly proportional to ALT activity.

• ALT reaction: L-alanine + 2-oxoglutarate → pyruvate + L-glutamate.
• Indicator reaction: pyruvate + NADH + H+ → L-lactate + NAD+ (catalyzed by LDH).
• Typical reagent composition: Tris buffer approximately 100 mmol/L at pH 7.15 (37°C), L-alanine 400–500 mmol/L, NADH approximately 0.18 mmol/L, LDH ≥1,200–2,000 U/L, 2-oxoglutarate 15–18 mmol/L as the start reagent, and pyridoxal-5′-phosphate 0.1 mmol/L in IFCC-standardized formulations.
• Procedure: mix sample with reagent 1 and pre-incubate for 60–90 seconds to consume endogenous pyruvate and complete pyridoxal phosphate activation; add 2-oxoglutarate to initiate the ALT reaction; observe a lag phase of approximately 60 seconds; then record the absorbance decrease over 60–180 seconds using a least-squares linear fit.
• Calculation: ALT (U/L) = (ΔA/min × V_total × 1000) / (ε × path length × V_sample), where ε for NADH is 6.22 × 10³ L·mol⁻¹·cm⁻¹ at 340 nm and the path length is 1.0 cm. For example, with a 0.20 mL sample in a 2.20 mL total volume, the calculation factor is approximately 1768.
• Performance: within-laboratory imprecision is typically below 3–5% CV at normal concentrations, with linearity commonly extending to approximately 600 U/L.

Reitman–Frankel Colorimetric (2,4-Dinitrophenylhydrazine) Method

This classical endpoint method measures the pyruvate generated during a fixed incubation. Pyruvate reacts with 2,4-dinitrophenylhydrazine under alkaline conditions to form a red-brown hydrazone, and the color intensity is read at 505–520 nm against a pyruvate calibration curve. A sample blank is required to correct for endogenous pyruvate and ketone bodies.

• Advantages: simple instrumentation, low reagent cost, and suitability for basic laboratories.
• Limitations: lower analytical sensitivity and precision, non-specific hydrazone formation, and susceptibility to background interference; largely superseded by the kinetic UV method.

Dry Chemistry and Point-of-Care Testing

Multilayer dry-film slide technologies incorporate the ALT/LDH/NADH reaction system and quantify activity by reflectance photometry. Whole blood from a fingerstick can be analyzed on compact or portable instruments with results available in 10–15 minutes. These platforms are valuable in blood bank screening, occupational health programs, physician offices, and resource-limited or remote settings, provided lot-specific calibration and periodic comparison with a central laboratory are maintained.

Calibration and Quality Control

• Use calibrators traceable to the IFCC reference measurement procedure at 37°C.
• Run two-level quality control materials (normal and elevated) in each analytical session, monitored with Levey–Jennings charts and Westgard multi-rules.
• Verify the analytical measurement range and apply a documented dilution protocol for samples exceeding the upper limit, typically a 1:5 to 1:10 saline dilution with result multiplication.
• Participate in external quality assessment or proficiency testing programs to ensure inter-laboratory harmonization.
• Verify photometric wavelength accuracy, cuvette cleanliness, and reaction temperature stability at 37 ± 0.1°C during preventive maintenance.

Applications

• Detection and follow-up of acute viral hepatitis, where ALT frequently exceeds ten times the upper reference limit.
• Long-term management of chronic hepatitis B and hepatitis C, including antiviral treatment response monitoring.
• Screening and longitudinal surveillance of metabolic dysfunction-associated steatotic liver disease (MASLD/NAFLD).
• Evaluation of alcoholic liver disease in conjunction with the AST/ALT (De Ritis) ratio.
• Drug-induced liver injury surveillance in clinical trials, pharmacovigilance programs, and Hy's Law assessments.
• Blood donor screening as a surrogate marker of liver abnormalities and transfusion-transmissible infection risk.
• Occupational health monitoring of workers exposed to industrial hepatotoxins.
• Preoperative assessment, insurance medical examinations, and routine health checkups.
• Veterinary clinical biochemistry and preclinical hepatotoxicity studies in pharmaceutical research.

FAQ

What is the normal range for ALT?

Typical adult intervals at 37°C are approximately 7–33 U/L for women and 7–45 U/L for men, although some laboratories use a broader range such as 7–56 U/L. Reference limits vary with age, sex, body mass index, and methodology, so laboratory-specific values should always be applied for interpretation.

Does the ALT test require fasting?

Fasting is not strictly required, but an 8–12 hour fast is commonly recommended to reduce lipemia-related interference. Patients should also avoid alcohol consumption and strenuous physical exercise for at least 24 hours before sample collection, as both can transiently elevate ALT activity.

Which testing method is the most accurate?

The IFCC kinetic ultraviolet method at 37°C, performed on automated chemistry analyzers with traceable calibrators, provides the highest precision, linearity, and inter-laboratory comparability, and is the method recommended by international clinical chemistry organizations.

What can cause falsely abnormal ALT results?

Hemolysis is the most common cause of falsely elevated results because erythrocytes contain ALT. Lipemia and severe icterus can interfere photometrically. Physiological factors including intense exercise, alcohol, hepatotoxic medications, and herbal supplements can cause genuine but transient elevations. Reagents lacking pyridoxal-5′-phosphate may underestimate activity in patients with vitamin B6 deficiency.

How are extremely elevated samples handled?

Samples exceeding the analytical measurement range are diluted with isotonic saline, re-analyzed, and the result is multiplied by the dilution factor. Most automated systems perform this dilution automatically and flag the corrected value for review.

How quickly are results available?

On automated chemistry analyzers, results are typically available within 30–60 minutes of sample receipt. Point-of-care dry-chemistry platforms can deliver quantitative ALT results in approximately 10–15 minutes from a fingerstick blood sample.